Yasmin Genevieve Hernandez-Barco

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Avinash R. Kambadakone · 2 shared papers, 2026 · strength 0.57
   • Paper Pancreatic Cancer Risk in Patients With Low-Risk Cystic Lesions. DOI 10.1001/jamanetworkopen.2026.13808↗
   • Paper Disparities in the diagnosis and management of exocrine pancreatic insufficiency in resectable vs metastatic pancreatic… DOI 10.1093/oncolo/oyag084↗
2. Carlos Fernández-del Castillo · 2 shared papers, 2021–2026 · strength 0.39
   • Paper Disparities in the diagnosis and management of exocrine pancreatic insufficiency in resectable vs metastatic pancreatic… DOI 10.1093/oncolo/oyag084↗
   • Paper Preoperative cholangitis is an independent risk factor for mortality in patients after pancreatoduodenectomy for pancre… DOI 10.1016/j.amjsurg.2020.07.025↗
3. Arya Haj Mirzaian · 1 shared paper, 2026 · strength 0.30
   • Paper Pancreatic Cancer Risk in Patients With Low-Risk Cystic Lesions. DOI 10.1001/jamanetworkopen.2026.13808↗
4. Ramin Khorasani · 1 shared paper, 2026 · strength 0.30
   • Paper Pancreatic Cancer Risk in Patients With Low-Risk Cystic Lesions. DOI 10.1001/jamanetworkopen.2026.13808↗
5. Kunal Jajoo · 1 shared paper, 2026 · strength 0.30
   • Paper Pancreatic Cancer Risk in Patients With Low-Risk Cystic Lesions. DOI 10.1001/jamanetworkopen.2026.13808↗
6. David Tsai Ting · 1 shared paper, 2026 · strength 0.27
   • Paper Disparities in the diagnosis and management of exocrine pancreatic insufficiency in resectable vs metastatic pancreatic… DOI 10.1093/oncolo/oyag084↗
7. Peiyun Ni · 1 shared paper, 2026 · strength 0.27
   • Paper Disparities in the diagnosis and management of exocrine pancreatic insufficiency in resectable vs metastatic pancreatic… DOI 10.1093/oncolo/oyag084↗
8. Fateh Bazerbachi · 1 shared paper, 2026 · strength 0.27
   • Paper Disparities in the diagnosis and management of exocrine pancreatic insufficiency in resectable vs metastatic pancreatic… DOI 10.1093/oncolo/oyag084↗
9. Colin D. Weekes · 1 shared paper, 2026 · strength 0.27
   • Paper Disparities in the diagnosis and management of exocrine pancreatic insufficiency in resectable vs metastatic pancreatic… DOI 10.1093/oncolo/oyag084↗
10. Vahid Yaghmai · 1 shared paper, 2025 · strength 0.18
    • Paper Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic … DOI 10.3390/cancers17111886↗
11. Temel Tirkes · 1 shared paper, 2025 · strength 0.18
    • Paper Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic … DOI 10.3390/cancers17111886↗
12. Lixia Wang · 1 shared paper, 2025 · strength 0.18
    • Paper Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic … DOI 10.3390/cancers17111886↗
13. Camila Lopes Vendrami · 1 shared paper, 2025 · strength 0.18
    • Paper Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic … DOI 10.3390/cancers17111886↗
14. James Leonard Buxbaum · 1 shared paper, 2025 · strength 0.18
    • Paper Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic … DOI 10.3390/cancers17111886↗
15. Sehrish Javed · 1 shared paper, 2025 · strength 0.18
    • Paper Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic … DOI 10.3390/cancers17111886↗
16. Christie Y. Jeon · 1 shared paper, 2025 · strength 0.18
    • Paper Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic … DOI 10.3390/cancers17111886↗
17. Stephen Jacob Pandol · 1 shared paper, 2025 · strength 0.18
    • Paper Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic … DOI 10.3390/cancers17111886↗
18. Srinivas Gaddam · 1 shared paper, 2025 · strength 0.18
    • Paper Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic … DOI 10.3390/cancers17111886↗
19. Frank H. Miller · 1 shared paper, 2025 · strength 0.18
    • Paper Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic … DOI 10.3390/cancers17111886↗
20. Debiao Li · 1 shared paper, 2025 · strength 0.18
    • Paper Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic … DOI 10.3390/cancers17111886↗
21. Touseef Ahmad Qureshi · 1 shared paper, 2025 · strength 0.18
    • Paper Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic … DOI 10.3390/cancers17111886↗
22. Wolfram Goessling · 1 shared paper, 2025 · strength 0.18
    • Paper Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic … DOI 10.3390/cancers17111886↗
23. Eli P. Darnell · 1 shared paper, 2021 · strength 0.12
    • Paper Preoperative cholangitis is an independent risk factor for mortality in patients after pancreatoduodenectomy for pancre… DOI 10.1016/j.amjsurg.2020.07.025↗
24. Maximilian Weniger · 1 shared paper, 2021 · strength 0.12
    • Paper Preoperative cholangitis is an independent risk factor for mortality in patients after pancreatoduodenectomy for pancre… DOI 10.1016/j.amjsurg.2020.07.025↗
25. Kumar Krishnan · 1 shared paper, 2021 · strength 0.12
    • Paper Preoperative cholangitis is an independent risk factor for mortality in patients after pancreatoduodenectomy for pancre… DOI 10.1016/j.amjsurg.2020.07.025↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.